YUNGJIN PHARM. CO., LTD Logo

YUNGJIN PHARM. CO., LTD

003520 | KO

Overview

Corporate Details

ISIN(s):
KR7003520004
LEI:
Country:
South Korea
Address:
서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층, 송파구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Regulatory Filings
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 6.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-08-14 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 695.0 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 879.7 KB
2025-08-13 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.1 KB
2025-08-01 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-07-31 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 12.9 KB
2025-07-25 00:00
Share Issue/Capital Change
[기재정정]신규시설투자등
Korean 13.7 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 90.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 681.6 KB
2025-05-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-03-28 00:00
AGM Information
정기주주총회결과
Korean 33.7 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.7 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.2 MB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 492.1 KB

Automate Your Workflow. Get a real-time feed of all YUNGJIN PHARM. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for YUNGJIN PHARM. CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for YUNGJIN PHARM. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

REGENXBIO Inc. Logo
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX
Rein Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.
United States of America
RNTX
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel
REKA
Relay Therapeutics, Inc. Logo
Developing precision medicines for oncology & genetic diseases by analyzing protein motion.
United States of America
RLAY
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland
RLF
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia
REPL
REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America
RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea
102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America
RZLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.